Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ELDN
ELDN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ELDN News
Avaí Bio Completes GMP Master Cell Bank for Anti-Aging Therapy
4h ago
Newsfilter
NewcelX Completes Successful FDA Meeting, Advancing Diabetes Treatment
Jul 01 2026
Newsfilter
Biotech Sector Update: FDA and EU Approvals
Jun 26 2026
NASDAQ.COM
Natera Partners with Eledon for Kidney Transplant Trial Using Prospera Test
Jun 25 2026
NASDAQ.COM
Eledon Pharmaceuticals Reports Positive Long-Term Data for Tegoprubart in Kidney Transplantation
Jun 23 2026
NASDAQ.COM
Eledon Reports Long-Term Data on Tegoprubart in Kidney Transplantation
Jun 22 2026
Newsfilter
Eledon Pharmaceuticals Achieves Breakthrough in Diabetes Study
Jun 08 2026
Newsfilter
Eledon Pharmaceuticals to Present New Research at Diabetes Conference
Jun 04 2026
Newsfilter
NewcelX Schedules Pre-IND Meeting with FDA to Advance Type 1 Diabetes Treatment
May 27 2026
Newsfilter
Eledon Pharmaceuticals Q1 Earnings Miss Expectations
May 13 2026
seekingalpha
NewcelX Collaborates with Eledon to Advance Diabetes Treatment
Apr 20 2026
Newsfilter
Cell Therapy Market Set to Nearly Double by 2035
Apr 06 2026
Newsfilter
Eledon Pharmaceuticals Reports Expanded Net Loss for FY 2025 and Operational Updates
Mar 20 2026
NASDAQ.COM
Eledon Pharmaceuticals Reports FY 2025 Earnings Beat Expectations
Mar 19 2026
seekingalpha
Eledon Pharmaceuticals Reports Positive Data on Tegopribart for Type 1 Diabetes
Mar 16 2026
seekingalpha
Eledon Pharmaceuticals Receives FDA Orphan Drug Designation
Mar 10 2026
seekingalpha
Show More News
